Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 26

Trial Status

Completed1
Recruiting1
Terminated2
Other3

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT04174352Early Phase 1Recruiting
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
ERα+ Breast CancerESR1 Gene Mutation
PrincipalinvestigatorStart date: 2020-10-20
NCT03911973Phase 1/2Active Not Recruiting
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
TNBC - Triple-Negative Breast Cancer
PrincipalinvestigatorStart date: 2019-04-17
NCT03733119Phase 2Terminated
ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer
Triple Negative Breast Cancer
PrincipalinvestigatorStart date: 2018-11-13
NCT03090165Phase 1/2Active Not Recruiting
Ribociclib and Bicalutamide in AR+ TNBC
Triple Negative Breast Cancer
PrincipalinvestigatorStart date: 2018-05-07
NCT03301350Phase 2Completed
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Breast CancerTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2017-11-07
NCT03186937Phase 2Terminated
A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer
Breast CancerTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2017-08-10
NCT07706179Phase 2Not Yet Recruiting
Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
HR+/HER2+ Breast CancerMetastatic Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT04174352Early Phase 1PrincipalInvestigator

FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

ERα+ Breast CancerESR1 Gene Mutation
Recruiting
NCT03911973Phase 1/2PrincipalInvestigator

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

TNBC - Triple-Negative Breast Cancer
Active Not Recruiting
NCT03733119Phase 2PrincipalInvestigator

ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer
Terminated
NCT03090165Phase 1/2PrincipalInvestigator

Ribociclib and Bicalutamide in AR+ TNBC

Triple Negative Breast Cancer
Active Not Recruiting
NCT03301350Phase 2PrincipalInvestigator

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Breast CancerTriple Negative Breast Cancer
Completed
NCT03186937Phase 2PrincipalInvestigator

A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer

Breast CancerTriple Negative Breast Cancer
Terminated
NCT07706179Phase 2PrincipalInvestigator

Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer

HR+/HER2+ Breast CancerMetastatic Breast Cancer
Not Yet Recruiting

All 7 trials loaded